Abstract
The discovery of specific opiate receptors (Simon et al., 1973; Pert and Snyder, 1973) and the identification of naturally occurring peptides possessing opiatelike activity (endorphins) (Hughes et al., 1975; Li and Chung, 1976; Li et al., 1976; Bradbury et al., 1976; Chrétien et al., 1976) have led to considerable research and speculation regarding the relationship of the endorphin system to psychiatric illness (Usdin et al., 1979; Verebey et al., 1978). The mood-altering and calming effects of exogenous opiates (Jaffe and Martin, 1975), the regional brain distribution of opiate receptors (Goldstein, 1976; Goldstein and Cox, 1977), and the behavioral effects of administered endorphins to rats (Bloom et al., 1976) suggested potential relationships between the endogenous opioid systems and emotional behavior. Although initial endorphin-behavioral hypotheses focused on etiologic relevance to schizophrenia (Bloom et al., 1976; Segal et al., 1977), alterations in endorphin function have been hypothesized to be reflected in disorders of mood (Byck, 1976; Belluzzi and Stein, 1977; Gold and Byck, 1978).
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
Ambinder, R. F., and Schuster, M. M., 1979, Endorphins: New gut peptides with a familiarface, Gastroenterology 77:1132.
Angst, J., Autenrieth, V., Brem, F., Koukkou, M., Meyer, H., Stassen, H. H., and Storck, U., 1979, Preliminary results of treatment with ß-endorphin in depression, in: Endorphins in Mental Health Research ( E. Usdin, W. E. Bunney, Jr., and N. S. Kline), pp. 518–528, Macmillan Co., New York.
Belluzzi, J. D., and Stein, L., 1977, Enkephalin may mediate euphoria and drive reward, Nature (London) 266: 556.
Bloom, F., Segal, D., Ling, N., and Guillemin, R., 1976, Endorphins: Profound behavioral effects in rats suggest new etiological factors in mental illness, Science 194: 630.
Bloom, F., Bayon, A., Battenberg, E., French, E., Koda, L., Koob, G., Le Moal, M., Rossier, J., and Schoemaker, W., 1980, Endorphins: Developmental, cellular and behavioral aspects, in: Neural Peptides and Neuronal Communication (E. Costa and M. Trabucchi, eds.)., Advances in Biochemical Psychopharmacology, Vol. 22, pp. 619–632, Raven Press, New York.
Boyd, A. E., 3rd, and Reichlin, S., 1978, Neural control of prolactin secretion in man, Psychoneuroendocrinology 3: 113.
Bradbury, A. F., Smyth, D. G., and Snell, C. R., 1976, Lipotropin: Precursor to two biologically active peptides, Biochem. Biophys. Res. Commun. 69: 950.
Brown, W. A., and Shuey, I., 1980, Response to dexamethasone and subtype of depression, Arch. Gen. Psychiatry 37: 747.
Bruni, J. F., Van Vugt, D., Marshall, S., and Meites, J., 1977, Effects of naloxone, morphine and methionine enkephalin on serum prolactin, luteinizing hormone, follicle stimulating hormone, thyroid stimulating hormone and growth hormone, Life Sci. 21: 461.
Bucknill, J. D., and Tuke, D. H., 1858, Manual of Psychological Medicine, Philadelphia. Bunney, W. E., Jr., and Hamburg, D. A., 1963, Methods for reliable longitudinal observation of behavior, Arch. Gen. Psychiatry 9: 280.
Byck, R., 1976, Peptide transmitters: A unifying hypothesis for euphoria, respiration, sleep and the action of lithium, Lancet 2: 72.
Carroll, B. J., Curtis, G. C., and Mendels, J., 1976a, Neuroendocrine regulation in depres- sion I. Limbic system–adrenocortical dysfunction, Arch. Gen. Psychiatry 33: 1039.
Carroll, B. J., Curtis, G. C., and Mendels, J., 1976b, Neuroendocrine regulation in depression II. Discrimination of depressed from non-depressed patients Arch. Gen. Psychiatry 33: 1051.
Chrétien, M., Benjannet, S., Dragon, N., Seidah, N. G., and Lis, M., 1976, Isolation of peptides with opiate activity from sheep and human pituitaries: Relationship to betalipotropin, Biochem. Biophys. Res. Commun. 72: 472.
Comfort, A., 1977, Morphine as an antipsychotic. Relevance of a 19th century therapeutic fashion, Lancet 2: 448.
Davis, G. C., Bunney, W. E., Jr., DeFraites, E. G., Kleinman, J. E., van Kammen, D. P., Post, R. M., and Wyatt, R. J., 1977, Intravenous naloxone administration in schizophrenia and affective illness, Science 197: 74.
Davis, G. C., Bunney, W. E., Jr., Buchsbaum, M. S., DeFraites, E. G., Duncan, W., Gillin, J. C., van Kammen, D. P., Kleinman, J., Murphy, D. L., Post, R. M., Reus, V., and Wyatt, R. J., 1979, Use of narcotic antagonists to study the role of endorphins in normal and psychiatric patients, in Endorphins in Mental Health Research (E. Usdin, W. E. Bunney, Jr., and N. S. Kline, eds.)pp. 393-406, Macmillan Co., New York.
Davis, G. C., Extein, I., Reus, V., Hamilton, W., Post, R. M., Goodwin, F. K., and Bunney, W. E., Jr., 1980, Failure of naloxone to reduce manic symptoms, Am. J. Psychiatry 137: 1586.
Emrich, H. M., Höllt, V., Kissling, W., Fischler, M., Laspe, H., Heinemann, H., von Zerssen, D., and Herz, A., 1979, ß-Endorphin-like immunoreactivity in cerebrospinal fluid and plasma of patients with schizophrenia and other neuropsychiatric disorders, Pharmakopsychiatr. Neuro-Psychopharmakol. 12: 269.
Engel, G. L., 1975, Psychophysiological gastrointestinal disorders II. Intestinal disorders, in Comprehensive Textbook of Psychiatry ( A. M. Freedman, H. I. Kaplan, and B. J. Sadock, eds.), Vol. 2, pp. 1643–1648, Williams & Wilkins, Baltimore.
Enjalbert, A., Ruberg, M., Arancibia, S., Priam, M., and Kordon, C., 1979, Endogenous opiates block dopamine inhibition of prolactin secretion in vitro, Nature (London) 280: 595.
Extein, I., Goodwin, F. K., Lew y, A. J., Schoenfeld, R. I., Fakhuri, L. R., Gold, M. S., and Redmond, D. E., Jr., 1979a, Behavioral and biochemical effects of FK 33–824, a parenterally and orally active enkephalin analogue, in: Endorphins in Mental Health Research (E. Usdin, W. E. Bunney, Jr., and N. S. Kline, eds.), pp. 279-292, Macmillan Co., New York.
Extein, I., Pickar, D., Gold, P. W., Gold, M. S., Pottash, A. L. C., Sweeney, D. R., Ross, R. J., Rebar, R., Martin, D., and Goodwin, F. K., 1979b, Methadone and morphine in depression, Annual Meeting of the American College of Neuropsychopharmacology, San Juan, Puerto Rico.
Extein, I., Pottash, A. L. C., Gold. M. S., Sweeney, D. R., Martin, D. M., and Goodwin, F. K., 1980, Deficient prolactin response to morphine in depressed patients, Am. J. Psychiatry 137: 845.
Fink, M., Simeon, J., Itil, T. M., and Freedman, A. M., 1970, Clinical antidepressant activity of cyclazocine—a narcotic antagonist, Clin. Pharmacol. Ther. 11: 41.
Foley, K. M., Kourides, C. E., Inturrisi, C. E., Kaiko, R. F., Zaroulis, C. G., Posner, J. B., Houde, R. W., and Li, C. H., 1979, ß-Endorphin: Analgesic and hormonal effects in humans, Proc. Natl. Acad. Sci. USA 76: 5377.
Gerner, R. H., Catlin, D. H., Gorelick, D. A., Hui, K. K., and Li, C. H., 1980, Betaendorphin: Intravenous infusion causes behavioral change in psychiatric inpatients, Arch. Gen. Psychiatry 37: 642.
Gold, M. S., and Byck, R., 1978, Endorphins, Lithium, and naloxone: Their relationship to pathological and drug-induced manic-euphoric states, in The International Challenge of Drug Abuse (R. C. Peterson, ed.), National Institute on Drug Abuse Research Monograph Series 19, pp. 192–209, DHEW, Washington, D.C.
Gold, M. S., Donabedian, R. K., Dillard, M., Slobetz, F. W., Riordan, C. E., and Kleber, H. D., 1977, Antipsychotic effect of opiate agonists, Lancet 2: 398.
Gold, M. S., Redmond, D. E., Jr., Donabedian, R. K., Goodwin, F. K., and Extein, I., 1978a, Increase in serum prolactin by exogenous and endogenous opiates: Evidence for antidopamine and antipsychotic effects, Am. J. Psychiatry. 135: 1415.
Gold, M. S., Redmond, D. E., Jr., and Kleber, H. D., 1978b, Clonidine blocks acute opiate-withdrawal symptoms, Lancet 2: 599.
Gold, M. S., Pottash, A. L. C., Sweeney, D. R., Kleber, H. D., and Redmond, D. E., Jr., 1979a, Rapid opiate detoxification: Clinical evidence of antidepressant and antipanic effects of opiates, Am. J. Psychiatry. 136: 982.
Gold, M. S., Redmond, D. E., Jr., and Kleber, H. D., 1979b, Noradrenergic hyperactivity in opiate withdrawal supported by clonidine reversal of opiate withdrawal, Am. J. Psychiatry. 136: 100.
Gold, P. W., Extein, I., Pickar, D., Rebar, R., Ross, R., and Goodwin, F. K., 1980, Suppression of plasma cortisol in depressed patients by acute intravenous methadone infusion, Am. J. Psychiatry. 137: 862.
Goldstein, A., 1976, Opioid peptides (endorphins) in pituitary and brain, Science 193: 1081.
Goldstein, A., and Cox, B. M., 1977, Opioid peptides (endorphins) in pituitary and brain, Psychoneuroendocrinology 2: 11.
Goodwin, F. K., and Extein, I. L., 1979, The biological basis of affective disorders, in Progress in the Functional Psychoses (R. Cancro, L. Sheyer, and M. Kesselman, eds.), pp. 129-252, Spectrum Publishers, New York.
Guidotti, A., and Grandison, L., 1979, Participation of endorphins in the regulation of pituitary function, in Endorphins in Mental Health Research (E. Usdin, W. E. Bunney, Jr., and N. S. Kline, eds.), pp. 416-422, Macmillan Co., New York.
Guillemin, R., Vargo, T., Rossier, J., Minick, S., Ling, N., Rivier, C., Vale, W., and Bloom, F. E., 1977, ß-Endorphin and adrenocorticotropin are secreted concomitantly by the pituitary gland, Science 197: 1367.
Gunne, L. M., Lindström, L., and Terenius, L., 1977, Naloxone-induced reversal of schizophrenic hallucinations, J. Neural Transm. 40: 13.
Haertzen, C. A., and Hooks, N. T., Jr., 1969, Changes in personality and subjective experience associated with the chronic administration and withdrawal of opiates, J. Nerv. Ment. Dis. 148: 606.
Hamilton, M., 1960, A rating scale for depression, J. Neurol. Neurosurg. Psychiatry. 23: 56.
Ho., W. K., Wen, H. L., and Fung, K. P., 1977, Comparison of plasma hormonal levels between heroin addicted and normal subjects, Clin. Chim. Acta 75: 415.
Holaday, J. W., and Loh, H. H., 1979, Endorphin—opiate interactions with neuroendocrine systems, in Neurochemical Mechanisms of Opiate Ligands (H. H. Loh and D. H. Ross, eds.), Advances in Biochemical Psychopharmacology, Vol. 20, pp. 227–257, Raven Press, New York.
Holaday, J. W., Law, P. Y., Tseng, L. G., Loh, H. H., and Li, C. H., 1977, ß-Endorphin: Pituitary and adrenal glands modulate its action, Proc. Natl. Acad. Sci. USA 74: 4628.
Hughes, J., Smith, T. W., Kosterlitz, H., Fothergill, L. A., Morgan, B. A., and Morris, H. R., 1975, Identification of two related pentapetides from the brain with potent opiate agonist activity, Nature (London) 258: 577.
Iwamoto, E. T., and Way, E. L., 1979, Opiate actions and catecholamines, in Neurochemical Mechanisms of Opiates and Endorphins (H. H. Loh and D. H. Ross, eds.), Advances in Biochemical Psychopharmacology, Vol. 20, pp. 357–407, Raven Press, New York.
Jaffe, J. H., and Martin, W. R., 1975, Narcotic analgesics and antagonists, in The Pharmacological Basis of Therapeutics (L. S. Goodman and A. Gilman, eds.), pp. 245-283, Macmillan Co., New York.
Janowsky, D. S., Judd, L. L., Huey, L. Y., Roitman, N., Parker, D., and Segal, D. S., 1978, Naloxone effects on manic symptoms and growth hormone levels, Lancet 2: 320.
Janowsky, D. S., Judd, L. L., Huey, L. Y., and Segal, D. S., 1979, Effects of naloxone in normal, manic and schizophrenic patients: Evidence for alleviation of manic symptoms, in Endorphins in Mental Health Research (E. Usdin, W. E. Bunney, Jr., and N. S. Kline, eds.), pp. 435-447, Macmillan Co., New York.
J¢rgensen, A., Fog, R., and Veilis, B., 1979, Synthetic enkephalin analogue in treatment of schizophrenia, Lancet 1: 935.
Judd, L. L., Janowsky, D. S., Segal, D. S., and Huey, L. Y., 1980, Naloxone-induced behavioral and physiological effects in normal and manic subjects, Arch. Gen. Psychiatry. 37: 583.
Kalin, N.H., Risch, S.C., Cohen, R. M., Insel, T., and Murphy, D. L. 1980, Dexamethasone fails to suppress ß-endorphin plasma concentrations in humans and rhesus monkeys, Science 209: 827.
Kline, N. S., and Lehmann, H. E., 1979, ß-Endorphin therapy in psychiatric patients, in Endorphins in Mental Health Research (E. Usdin, W. E. Bunney, Jr., and N. S. Kline, eds.), pp. 500-517, Macmillan Co., New York.
Kline, N. S., Li, C. H., Lehmann, H. E., Lajtha, A., Laski, E., and Cooper, T., 1977, (ß-Endorphin induced changes in schizophrenic and depressed patients, Arch. Gen. Psychiatry. 34: 1111.
Labrie, F., Dupont, A., Cusan, L., Lissitzky, J. C., Lepine, J., Raymond, V., and Coy, D. H., 1979, Effects of endorphins and their analogues on prolactin and growth hormone secretion, in Endorphins in Mental Health Research (E. Usdin, W. E. Bunney, Jr., and N. S. Kline, eds.),pp. 335-343, Macmillan Co., New York.
Lehmann, H. E., Ananth, J. V., Geagea, K. C., and Ban, T. A., 1971, Treatment of depression with Dexedrine and Demerol, Curr. Ther. Res. 13: 42.
Lehmann, H., Vasavan Nair, N. P., and Kline, N. S., 1979, ß-Endorphin and naloxone in psychiatric patients: Clinical and biological effects, Am. J. Psychiatry 136: 762.
Li, C. H., and Chung, D., 1976, Isolation and structure of an untriakontapeptide with opiate activity from camel pituitary glands, Proc. Natl. Acad. Sci. USA 73: 1145.
Li, C. H., Chung, D., and Doneen, B. A., 1976, Isolation characterization and opiate activity of beta-endorphin from human pituitary glands, Biochem. Biophys. Res. Commun. 72: 1542.
Lindström, L. H., Widerlöv, E., Gunne, L. -M., Wahlström, A., and Terenius, L., 1978, Endorphins in human cerebrospinal fluid: Clinical correlations to some psychotic states, Acta Psychiatr. Scand. 57: 153.
Lord, J. A., Waterfield, A. A., Hughes, J., and Kosterlitz, H. W., 1977, Endogenous opioid peptides: Multiple agonists and receptors, Nature (London) 267: 495.
Mains, R. E., Eipper, B. A., and Ling, N., 1977, Common precursor to corticotropins and endorphins, Proc. Natl. Acad. Sci. USA 74: 3014.
Martin, W. R., Jasinski, D. R., Haertzen, C. A., Kay, D. C., Jones, B. E., Mansky, P. A., and Carpenter, R. W., 1973, Methadone—A re-evaluation, Arch. Gen. Psychiatry. 28: 286.
Meyer, R. E., Schildkraut, J. J., Mirin, S. M., Orsulak, P. J., Randall, M., McDougle, M., Platz, P. A., Grab, E., and Babor, T., 1978, Opiates, catecholamines, behavior and mood, Psychopharmacologia. 56: 327.
Mirin, S. M., Meyer, R. E., and McNamee, H. B., 1976, Psychopathology and mood during heroin abuse: Acute vs. chronic effects, Arch. Gen. Psychiatry. 33: 1503.
Murphy, D. L., Campbell, I. C., and Costa, J. L., 1978, Current status of the indoleamine hypothesis of the affective disorders, in Psychopharmacology: A Generation of Progress (M. A. Lipton, A. DiMascio, and K. F. Killam, eds.), pp. 1249-1260, Raven Press, New York.
Naber, D., Pickar, D., Davis, G. C., Cohen, R. M., Jimerson, D. C., Elchisak, M. A., DeFraites, E. G., Kalin, N. H., and Buchsbaum, M. S., 1980a, Naloxone effects on ß-endorphin, cortisol, prolactin, growth hormone, HVA and MHPG in plasma of normal volunteers, Psychopharmacology 74: 125.
Naber, D., Pickar, D., Dionne, R. A., Bowie, D. L., Ewels, B. A., Moody, T. W., Soble, M. G., and Pert, C. G., 1980b, Assay of endogenous opiate receptor ligands in human CSF and plasma, Substance and Alcohol Actions/Misuse 1: 85.
Naber, D., Pickar, D., Post, R. M., van Kammen, D. P., Waters, R. N., Ballinger, J. C., Goodwin, F. K., and Bunney, W. E., Jr., 1981, Endogenous opioid receptor ligands and ß-endorphin-immunoreactivity in CSF of psychiatric patients and normal volunteers, Am. J. Psychiatry 138: 1457.
Overall, J. E., and Gorham, D. R., 1962, The brief psychiatric rating scale, Psychol. Rep. 10: 799.
Pert, C. B., and Garland, B. L., 1978, The mechanism of opiate agonist and antagonist action, in Hormone Receptors, Vol. II (L. Birnbaum and B. W. O’Malley, eds.),pp. 535-549, Academic Press, New York.
Pert, C. B., and Snyder, S. H., 1973, Opiate receptor: Demonstration in nervous tissue, Science 179: 1011.
Pickar, D., Cutler, N. R., Naber, D., Post, R. M., Pert, C. B., and Bunney, W. E., Jr., 1980, Plasma opioid activity and manic-depressive illness, Lancet 1: 937.
Pickar, D., Davis, G. C., Schulz, S. C., Extein, I., Wagner, R., Naber, D., Gold, P. W., van Kammen, D. P., Goodwin, F. K., Waytt, R. J., Li, C. H., and Bunney, W. E., Jr., 1981, Behavioral and biological effects of acute beta-endorphin injection in schizophrenic and depressed subjects, Am. J. Psychiatry 138: 160.
Reichard, J. D., 1947, Addiction: Some theoretical considerations as to its nature, cause, prevention and treatment, Am. J. Psychiatry. 103: 721.
Rolandi, E., and Barreca, T., 1978, Effects of two analgesic opiates (methadone and pentazocine) on the serum prolactin levels in breast cancer, Acta Endocrinol. (Copenhagen) 88: 452.
Rossier, J., French, E., Guillemin, R., and Bloom, F. E., 1980, On the mechanisms of the simultaneous release of immunoreactive ß-endorphin, ACTH and prolactin by stress, in Neural Peptides and Neuronal Communication (E. Costa and M. Trabucchi, eds.), pp. 363-376, Raven Press, New York.
Rubin, P., Swezey, S., and Blaschke, T., 1979, Naloxone lowers plasma prolactin in man, Lancet 1: 1293.
Sachar, E. J., Hellman, L., Roffwarg, H. P., Halpern, F. S., Fukushima, D. K., and Gallagher, T. F., 1973, Disrupted 24 hour patterns of cortisol secretion in psychotic depression, Arch. Gen. Psychiatry. 28: 19.
Sachar, E. J., Asnis, G., Nathan, R. S., Halbreich, U., Tabriz, M. A., and Halpern, F. S., 1980, Dextroamphetamine and cortisol in depression: Morning plasma cortisol levels suppressed, Arch. Gen. Psychiatry. 37: 755.
Savit, R. A., 1954, Extramural psychoanalytic treatment of a case of narcotic addiction, Am. J. Psychiatry. 2: 494.
Schildkraut, J. J., 1978, Current status of the catecholamine hypothesis of affective disorders, in Psychopharmacology: A Generation of Progress (M. A. Lipton, A. DiMascio, and K. F. Killam), pp. 1235-1248, Raven Press, New York.
Schlesser, M. A., Winokur, G., and Sherman, B. M., 1979, Genetic subtypes of unipolar primary depressive illness distinguished by hypothalamic—pituitary—adrenal axis activity, Lancet 1: 739.
Schiesser, M. A., Winokur, G., and Sherman, B. M., 1980, Hypothalamic—pituitary—adrenal axis activity in depressive illness: Its relationship to classification, Arch. Gen. Psychiatry 37: 737.
Schulz, S. C., Wagner, R., van Kammen, D. P., Rogol, A. D., Davis, G. C., Wyatt, R. S., Pickar, D., and Bunney, W. E., Jr., 1980, Prolactin response to ß-endorphin in man, Life Sci., 27: 1735.
Segal, D. S., Browne, R. G., Bloom, F., Ling, N., and Guillemin, R., 1977, ß-Endorphin: Endogenous opiate or neuroleptic?, Science 198: 411.
Simantov, R., and Snyder, S. H., 1977, Opiate receptor binding in the pituitary gland, Brain Res. 124: 198.
Simon, E. J., Hiller, J. M., and Edelman, I., 1973, Stereospecific binding of the potent narcotic analgesic [3H]etorphine to rat-brain homogenate, Proc. Natl. Acad. Sci. USA 70: 1947.
Snyder, S. H., 1978, The opiate receptor and morphine-like peptides in the brain, Am. J. Psychiatry. 135: 645.
Stubbs, W. A., Jones, A., Edwards, C. R. W., DeLitala, G., Jeffcoate, W. J., Ratter, S. J., Besser, G. M., Bloom, S. R., and Alberti, K. G. M. M., 1978, Hormonal and metabolic responses to an enkephalin analogue in normal man, Lancet 2: 1225.
Terenius, L., Wahlström, A., and Agren, H., 1977, Naloxone (Narcan) treatment in depression: Clinical observations and effects on CSF endorphins and monoamine metabolites, Psychopharmacologia. 54: 31.
Tolis, G., Hickey, J., and Guyda, H., 1975, Effects of morphine on serum growth hormone, cortisol, prolactin and thyroid stimulating hormone in man, J. Clin. Endocrinol. Metab. 41: 797.
Tolis, G., Dent, R., and Guyda, H., 1978, Opiates, prolactin, and the dopamine receptor, J. Clin. Endocrinol. Metab. 47: 200.
Usdin, E., Bunney, W. E., Jr., and Kline, N. S. (eds.), 1979, Endorphins in Mental Health Research, Macmillan Co., New York.
Verebey, K., Volavka, J., and Clouet, D., 1978, Endorphins in psychiatry: An overview and a hypothesis, Arch. Gen. Psychiatry 35: 877.
Volavka, J., Bauman, J., Pevnick, J., Reker, D., James, B., and Cho, D., 1981, Short-term hormonal effects of naloxone in man, Psychoneuroendocrinology 5: 225.
Wieder, H., and Kaplan, E. H., 1969, Drug use in adolescents: Psychodynamic meaning and pharmacogenic effect, Psychoanal. Study Child 24: 399.
Wikler, A., 1952, A psychodynamic study of a patient during experimental self-regulated readdiction to morphine, Psychoanal. Q. 26: 270.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1982 Plenum Publishing Corporation
About this chapter
Cite this chapter
Pickar, D., Extein, I., Gold, P.W., Summers, R., Naber, D., Goodwin, F.K. (1982). Endorphins and Affective Illness. In: Shah, N.S., Donald, A.G. (eds) Endorphins and Opiate Antagonists in Psychiatric Research. Springer, Boston, MA. https://doi.org/10.1007/978-1-4684-1119-5_22
Download citation
DOI: https://doi.org/10.1007/978-1-4684-1119-5_22
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4684-1121-8
Online ISBN: 978-1-4684-1119-5
eBook Packages: Springer Book Archive